Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Marchetti

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
Infectious Diseases and Therapy|January 21, 2025
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2Marta Colaneri, Marta Canuti, Ginevra Torrigiani, et al.
HIV Research & Clinical Practice|February 12, 2025
Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohortBenoit Trottier, Chia-Jui Yang, Dai Watanabe, et al.
Expert Review of Anti-Infective Therapy|August 17, 2020
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study)Francesca Bai, Chiara Aldieri, AnnaMaria Cattelan, et al.
BMC Infectious Diseases|October 16, 2023
EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE projectPontus Hedberg, Benedetta Varisco, Francesca Bai, et al.
Journal of Infection and Public Health|January 23, 2024
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern ItalyAndrea Lombardi, Simone Villa, Marta Colaneri, et al.
The Lancet Regional Health. Europe|July 22, 2024
All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort studyChristian Kraef, Erich Tusch, Sabine Singh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 23, 2023
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA networkAndrea Giacomelli, Roberta Gagliardini, Alessandro Tavelli, et al.
BMC Infectious Diseases|October 13, 2023
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestationsBenedetta Varisco, Francesca Bai, Sara De Benedittis, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 20, 2020
The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 diseaseAntonella d'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
Infectious Diseases and Therapy|June 3, 2024
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild-Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or RemdesivirFrancesca Bai, Tomaso Beringheli, Virginia Vitaletti, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
Infectious Diseases and Therapy|January 21, 2025
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2Marta Colaneri, Marta Canuti, Ginevra Torrigiani, et al.
HIV Research & Clinical Practice|February 12, 2025
Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohortBenoit Trottier, Chia-Jui Yang, Dai Watanabe, et al.
Expert Review of Anti-Infective Therapy|August 17, 2020
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study)Francesca Bai, Chiara Aldieri, AnnaMaria Cattelan, et al.
BMC Infectious Diseases|October 16, 2023
EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE projectPontus Hedberg, Benedetta Varisco, Francesca Bai, et al.
Journal of Infection and Public Health|January 23, 2024
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern ItalyAndrea Lombardi, Simone Villa, Marta Colaneri, et al.
The Lancet Regional Health. Europe|July 22, 2024
All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort studyChristian Kraef, Erich Tusch, Sabine Singh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 23, 2023
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA networkAndrea Giacomelli, Roberta Gagliardini, Alessandro Tavelli, et al.
BMC Infectious Diseases|October 13, 2023
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestationsBenedetta Varisco, Francesca Bai, Sara De Benedittis, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 20, 2020
The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 diseaseAntonella d'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
Infectious Diseases and Therapy|June 3, 2024
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild-Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or RemdesivirFrancesca Bai, Tomaso Beringheli, Virginia Vitaletti, et al.
Pageof 19